01
Inventory decreased 4.2%
Inventory changed -4.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$505,000→$484,000Comparable → current
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTLucid Diagnostics Inc.'s latest supported as-filed period reports revenue of $1.2M. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Inventory changed -4.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -163.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -12.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
LUCD · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-037596SEC ↗10-QAug 12, 2026Period Jun 30, 20260001437749-26-027335SEC ↗8-KJun 24, 2026Period Jun 24, 20260001493152-26-029943SEC ↗4May 21, 2026Period May 20, 20260001094891-26-000217SEC ↗8-KMay 14, 2026Period May 14, 20260001493152-26-022877SEC ↗10-QMay 13, 2026Period Mar 31, 20260001437749-26-016751SEC ↗8-KApr 24, 2026Period Apr 24, 20260001493152-26-018926SEC ↗8-KTransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| May 20, 2026Filed May 21, 2026 | Matheis DennisDirector | Open Market PurchaseDirect | 245,000 | $1 | $245,270 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed -5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed +48.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-018725